Keith R. Alexandra 4

What Happened

• Keith R. Alexandra, a director of Thermo Fisher Scientific (TMO), was credited with 66.02 stock units on March 28, 2026 as an award/acquisition under the company's Deferred Compensation Plan for Directors. Each unit is valued at $473.36, for a total value of approximately $31,251. These are derivative stock units convertible 1-for-1 into common shares (per footnote).

Key Details

• Transaction date: March 28, 2026; Form 4 filed March 31, 2026 (timely filing).
• Units/amount: 66.02 stock units at $473.36 per unit → ~ $31,251 total.
• Nature: Award/acquisition of deferred stock units (derivative), not a market purchase or sale.
• Conversion: Footnote F1 — each unit converts into one common share on a 1-for-1 basis.
• Plan terms: Footnote F2 — units represent deferred director retainer credited at quarter-end price; distributable as shares upon cessation of director service or a change of control.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context

• These units are part of routine director compensation deferral (not an open-market buy or sell). Deferred stock units are common for non-employee directors and do not indicate an immediate buy/sell signal; they convert to actual shares only upon distribution events described above.